Skip to main content
You have permission to edit this article.
Edit

Creative Biolabs’ γδ T Cell Development Service Built for Anti-Cancer Immunotherapy

By: Get News
Integrating profound biological expertise with comprehensive γδ T profiling and developmental technologies, Creative Biolabs plays a significant role in the development of innovative γδ T cell-based cancer therapeutics.

New York, USA – August 16, 2022 – In recent studies, γδ T cells have displayed potent anti-tumor efficacy against breast cancer, colon cancer, lung cancer, leukemia, and other cancers. Yet, there remain significant challenges to γδ T cell therapy today, despite its current application in clinical trials to treat cancer. For instance, this includes the low quantities of γδ T cells in peripheral blood, the difficulty of in vitro multiplication, and the challenges in developing T cell-based cancer medicines.

In response, Creative Biolabs has updated a broad range of γδ T cell development services, including but not limited to γδ T cell expansion, characterization, and production, in order to facilitate the development of T cell-based immunotherapy.

The two γδ T cell development services will be detailed as follows:

γδ T Cell Expansion

Since γδ T cells constitute a minority of T cells, their large-scale expansion is hard to realize efficiently and cost-effectively. With skilled experts in the research of γδ T cell activation and expansion, Creative Biolabs can offer a great diversity of in vitro or in vivo solutions as well as top-quality services for the activation and expansion of Vγ9Vδ2 T cells, accelerating the development of Vγ9Vδ2 T cell and non-Vγ9Vδ2 T cell-based immunotherapy. Based on research demonstrating that both Vγ9Vδ2 and non-Vγ9Vδ2 T cells possess potent anti-tumor activity against various cancer types, Creative Biolabs offers the following two T cell expansion services:

* Vγ9Vδ2 T cell activation and expansion

* Non-Vγ9Vδ2 T cell activation and expansion

γδ T Cell Characterization

During T cell development, variations in surface marker expression and cytokine release can lead to crucial changes in function. Thus, any additional characterization will offer better insights as well as improved therapeutics. With years of expertise in the field of γδ T cells, Creative Biolabs is distinctly qualified to help clients with their γδ T cell characterization projects and offers the flexibility required to achieve the strictest timelines and goals based on respective clients’ needs. In terms of T cell characterization, Creative Biolabs provides the following services:

* γδ T cell immunophenotype analysis by Abs

* γδ T cell morphology observation by TEM, SEM, and FCM

* γδ T cell phagocytic ability tests

* Impedance-based label-free real-time γδ T cells cytotoxicity assay

* CAR transduction for engineered γδ T cells

Explore more details about γδ T cell development service for anti-cancer immunotherapy by visiting https://gammadelta-t-therapy.creative-biolabs.com.

About Creative Biolabs

With decades of experience in the development of immunotherapies, Creative Biolabs has established itself as a market leader in novel drug discovery and development. Creative Biolabs continues to offer high-quality γδ T cell products as well as customized γδ T cell-based drug discovery services for its global clients.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://gammadelta-t-therapy.creative-biolabs.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.